Ocimum basilicum leaf essential oil and (-)-linalool reduce orofacial nociception in rodents: A behavioral and electrophysiological approach

Revista Brasileira de Farmacognosia

Volumn 21, Issue 6, 2011, Pages 1043-1051

  Venâncio, Antônio M ^a   Marchioro, Murilo ^a   Estavam, Charles S ^a   Melo, Mônica S ^a   Santana, Marília T ^a   Onofre, Alexandre S C ^a   Guimarães, Adriana G ^a   Oliveira, Makson G B ^a   Alves, Péricles B ^a   de Carvalho Pimentel, Hugo ^a   Quintans Jr , Lucindo J ^a  

^a FEDERAL UNIVERSITY OF SERGIPE   (Brazil)

Author keywords

CNS excitability; Essential oil; Linalool; Ocimum basilicum; Orofacial nociception

Indexed keywords

CAPSAICIN; ESSENTIAL OIL; FORMALDEHYDE; GLUTAMIC ACID; LEVO LINALOOL; LINALOOL; MORPHINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINOCICEPTION; ARTICLE; BASIL; BEHAVIOR; CONTROLLED STUDY; DENTATE GYRUS; DRUG ISOLATION; HIPPOCAMPUS; MALE; MOUSE; NERVE CELL EXCITABILITY; NERVOUS SYSTEM ELECTROPHYSIOLOGY; NOCICEPTION; NONHUMAN; OROFACIAL NOCICEPTION; PAIN; PLANT LEAF; RAT; UPPER LIP;

EID: 80054853552     PISSN: 0102695X     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0102-695X2011005000147     Document Type: Article

References (58)

1. Adams RP 2007. Identification of essential oil components by gas chromatography/mass spectroscopy. 4 ed. Illinois: Allured Publishing Corporation, Carol Stream.
2. Almeida RN, Araújo DAM, Goncalves JCR, Montenegro FC, Sousa DP, Leite JR, Mattei R, Benedito MAC, Carvalho JGB, Cruz JS, Maia JGS 2009. Rosewood oil induces sedation and inhibits compound action potential in rodents. J Ethnopharmacol 124: 440-443.
3. Almeida RN, Navarro DS, Barbosa-Filho JM 2001. Plants with central analgesic activity. Phytomedicine 8: 310-322.
4. Andersen P, Bliss TV, Skrede KK 1971. Unit analysis of hippocampal polulation spikes. Exp Brain Res 13: 208-221.
5. Ardjmand A, Fathollahi Y, Sayyah M, Kamalinejad M, Omrani A 2006. Eugenol depresses synaptic transmission but does not prevent the induction of long-term potentiation in the CA1 region of rat hippocampal slices. Phytomedicine 13: 146-151.
6. Batista PA, Werner MFP, Oliveira EC, Burgos L, Pereira P, Silva Brum LF, Santos ARS 2008. Evidence for the involvement of ionotropic glutamatergic receptors on the antinociceptive effect of (-)-linalool in mice. Neurosc Lett 440: 299-303.
7. Beirith A, Santos ARS, Calixto JB 2002. Mechanisms underlying the nociception and paw oedema caused by injection of glutamate into the mouse paw. Brain Res 924: 219-228.
8. Blank AF, Souza EM, Arrigoni-Blank MF, Paula JWA, Alves PB 2007. "Maria Bonita", uma cultivar de manjericão tipo linalol. Pesq Agropec Bras 42: 1811-1813.
9. Calixto JB, Beirith A, Ferreira J, Santos AR, Cechinel Filho V, Yunes RA 2000. Naturally occurring antinociceptive substances from plants. Phytother Res 14: 401-418.
10. Capuano A, Corato A, Treglia M, Tringali G, Russo CD, Navarra P 2009. Antinociceptive activity of buprenorphine and lumiracoxib in the rat orofacial formalin test: a combination analysis study. Eur J Pharmacol 605: 57-62.
11. Carlton SM, Zhou S, Coggeshall RE 1998. Evidence for the interaction of glutamate and NK1 receptors in the periphery. Brain Res 2: 229-238.
12. Ceccarelli I, Scaramuzzino A, Aloisi AM 1999. Effects of formalin pain in hippocampal c-fos expression in male and female rats. Pharmacol Biochem Behav 64: 797-802.
13. Clavelou P, Dallel R, Orliaguel T, Woda A, Raboisson P 1995. The orofacial formalin test in rats: effect of different formalin concentrations. Pain 62: 295-301.
14. Dallel R, Raboisson P, Clavelou P, Saade M, Woda A 1995. Evidence for a peripheral origin of the tonic nociceptive response to subcutaneous formalin. Pain 61: 11-16.
15. De Sousa DP, Gonçalves JC, Quintans-Júnior LJ, Cruz JS, Araujo DAM, Almeida RN 2006. Study of anticonvulsant effect of citronellol, a monoterpene alcohol, in rodents. Neurosci Lett 401: 231-235.
16. De Sousa DP, Quintans-Júnior LJ, Almeida RN 2007. Evaluation of the anticonvulsant activity of alfa-terpineol. Pharm Biol 45: 69-70.
17. Henry JL, Yashpal K, Pitcher GM, Chabot JG, Coderre TJ 1999. An evidence for tonic activation of NK-1 receptors during the second phase of the formalin test in the rat. J Neurosci 19: 6588-6598.
18. Holanda-Pinto SA, Pinto LMS, Guedes MA, Cunha GMA, Chaves MH, Santos FA, Rao VS 2008. Antinoceptive effect of triterpenoid α,β-amyrin in rats on orofacial pain induced by formalin and capsaicin. Phytomedicine 15: 630-634.
19. Honda K, Kitagawa J, Sessle BJ, Kondo M, Tsuboi Y, Yonehara Y, Iwata K 2008. Mechanisms involved in an increment of multimodal excitability of medullary and upper cervical dorsal horn neurons following cutaneous capsaicin treatment. Mol Pain 19: 4-59.
20. Hou M, Uddman R, Tajti J, Kanje M, Edvinsson L 2002. Capsaicin receptor immunoreactivity in the human trigeminal ganglion. Neurosci Lett 330: 223-226.
21. Hu JW, Fiorentino PM, Cairns BE, Sessle BJ 2005. Capsaicininduced inflammation within temporomandibular joint involves VR-1 receptor mechanisms. Oral Biosci Med 4: 241-248.
22. Ichikawa H, Sugimoto T 2001. VR1-immunoreactive primary sensory neurons in the rat trigeminal ganglion. Brain Res 890: 184-188.
23. Kamatou GPP, Viljoen AM 2008. Linalool - a review of a biologically active compound of commercial importance. Nat Prod Commun 3: 1183-1192.
24. Khanna S, Sinclair JG 1992. Responses in the CA1 region of the rat hippocampus to a noxious stimulus. Exp Neurol 117: 28-35.
25. Khanna S, Zheng F 1999. Morphine reversed formalin-induced CA1 pyramidal cell suppression via an effect on septohippocampal neural processing. Neuroscience 89: 61-71.
26. Lam DK, Sessle BJ, Hu JW 2009. Glutamate and capsaicin effects on trigeminal nociception II: activation and central sensitization in brainstem neurons with deep craniofacial afferent input. Brain Res 1253: 48-59.
27. Ling J, Campbell C, Heffernan TM, Greenough CG 2007. Shortterm prospective memory deficits in chronic back pain patients. Psychosom Med 69: 144-148.
28. Liu M-G, Chen J 2009. Roles of the hippocampal formation in pain information processing. Neurosci Bull 25: 237-266.
29. Lu X, Geng X, Zhang L, Zeng Y, Dong H, Yu H 2009. Substance P expression in the distal cerebrospinal fluid-contacting neurons and spinal trigeminal nucleus in formalininduced the orofacial inflammatory pain in rats. Brain Res Bull 78: 139-144.
30. Luccarini P, Childeric A, Gaydier AM, Voisin D, Dallel R 2006. The orofacial formalin test in the mouse: a behavioral model for studying physiology and modulation of trigeminal nociception. Pain 7: 908-914.
31. Luccarini P, Henry M, Alvarez Gaydier AM, Dallel R 2003. Contribution of neurokinin 1 receptors in the cutaneous orofacial cutaneous pain. Naunyn Schmiedebergs. Arch Pharmacol 368: 320-323.
32. Mazutti M, Beledelli B, Mossi AJ, Cansian RL, Dariva C, Oliveira JV, Paroul N 2006. Caracterização química de extratos de Ocimum basilicum L. obtidos através de extração com CO2 a altas pressões. Quim Nova 29: 1198-1202.
33. Melo MS, Sena LCS, Barreto FJN, Bonjardim LR, Almeida JRGS, Lima JT, Quintans-Júnior LJ 2010. Antinociceptive effect of citronellal in mice. Pharm Biol 48: 411-416.
34. Melzack R 2008. The future of pain. Nat Ver Drug Disov 7: 629.
35. Miranda HF, Sierralta F, Prieto JC 2009. Synergism between NSAIDs in the orofacial formalin test in mice. Pharmacol Biochem Behav 92: 314-318.
36. Narita M, Kaneko C, Miyoshi K, Nagumo Y, Kuzumaki N, Nakajima M, Nanjo K, Matsuzawa K, Yamazaki M, Suzuki T 2006. Chronic pain induces anxiety with concomitant changes in opioidergic function in the amygdala. Neuropsychopharmacol 31: 739-750.
37. Oliveira JS, Porto LA, Estevam CS, Siqueira RS, Alves PB, Niculau ES, Blank AF, Almeida RN, Marchioro M, Quintans-Júnior LJ 2009. Phytochemical screening and anticonvulsant property of Ocimum basilicum leaf essential oil. BLACPMA 8: 195-202.
38. +2 permeable currents in dorsal root ganglion cells. J Dent Res 76: 1737-1744.
39. Pace MC, Mazzariello L, Passavanti MB, Sansone P, Barbarisi M, Aurilio C 2006. Neurobiology of pain. J Cell Physiol 209: 8-12.
40. Peana AT, D'Aquila PS, Chessa ML, Moretti MDL, Serra G, Pippia P 2003. (-)- Linalool produces antinociception in two experimental models of pain. Eur J Pharmacol 460: 37-41.
41. Peana AT, D'Aquila PS, Panin F, Serra G, Pippia P, Moretti MDL 2002. Anti-inflammatory activity of linalool and linalyl acetate constituents of essential oils. Phytomedicine 9: 721-726.
42. Peana AT, De Montis MG, Sechi S, Sircana G, D'Aquila PS, Pippia P 2004. Effects of (-)-linalool in the acute hyperalgesia induced by carrageenan, L-glutamate and prostaglandin E2. Eur J Pharmacol 497: 279-284.
43. Peana AT, Marzocco S, Popolo A, Pinto A 2006. (-)-Linalool inhibits in vitro NO formation: Probable involvement in the antinociceptive activity of this monoterpene compound. Life Sci 78: 719-723.
44. Pellisier T, Pajot J, Dallel R 2002. The orofacial capsaicin test in rats: effects of different capsaicin concentrations and morphine. Pain 96: 81-87.
45. Porto LA, Siqueira JS, Seixas LN, Almeida JRGS, Quintans-Júnior LJ 2007. Íon channels role in epilepsy and considersof the antiepileptic drugs- a short review. J Epilepsy Clin Neurophysiol 13: 169-175.
46. Quintans-Júnior LJ, Souza TT, Leite BS, Lessa NMN, Bonjardim LR, Santos MRV, Alves PB, Blank AF, Antoniolli AR 2008a. Phythochemical screening and anticonvulsant activity of Cymbopogon winterianus Jowitt (Poaceae) leaf essential oil in rodents. Phytomedicine 15: 619-624.
47. Quintans-Júnior LJ, Almeida JRGS, Lima JT, Nunes XP, Siqueira JS, Oliveira LEG, Almeida RN, Athayde-Filho PF, Barbosa-Filho JM 2008b. Plants with anticonvulsant properties - a review. Rev Bras Farmacogn 18: 798-819.
48. Quintans-Júnior LJ, Melo MS, De Sousa DP, Araújo AAS, Onofre ACS, Gelain DP, Gonçalves JCR, Araújo DAM, Almeida JRGS, Bonjardim LR 2010. Antinociceptive activity of citronellal in formalin-, capsaicin- and glutamateinduced orofacial nociception in rodents and its action on nerve excitability. J Orofac Pain 24: 305-312.
49. Raboisson P, Dallel R 2004. The orofacial formalin test. Neurosci Biobehav Rev 28: 219-226.
50. Reanmongkol W, Matsumoto K, Watanabe H, Subhadhirasakul S, Sakai SI 1994. Antinociceptive and antipyretic effects of alkaloids extracted from the stem bark of Hunteria zeylanica. Biol Pharm Bull 17: 134513-134550.
51. Sanacora G, Zarate CA, Krystal JH, Manji HK 2008. Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders. Nature Rev 7: 426-437.
52. Shepherd JD, Huganir RL 2007. The cell biology of synaptic plasticity: AMPA receptor trafficking. Annu Rev Cell Dev Biol 23: 613-643.
53. Siqueira RS, Bonjardim LR, Araújo AAS, Araújo BES, Melo MGD, Oliveira MGB, Gelain DP, Silva FA, DeSantana JM, Albuquerque-Júnior RLC, Rocha RF, Moreira JCF, Antoniolli AR, Quintans-Júnior LJ 2010. Antinociceptive activity of atranorin in mice orofacial nociception tests. Z Naturforsch C 65: 1-11.
54. Stoll L, Seguin S, Gentile L 2007. Tricyclic antidepressants, but not the selective serotonin reuptake inhibitor fluoxetine, bind to the S1S2 domain of AMPA receptors. Arch Biochem Biophy 458: 213-219.
55. Vogt-Eisele AK, Weber K, Sherkheli MA, Panten J, Vielhaber G, Gisselmann G, Hatt H 2007. Monoterpenoid agonists of TRPV3. Br J Pharmacol 151: 530-540.
56. Waning J, Vriens J, Owsianik G, Stüwe L, Mally S, Fabian A, Frippiat C, Nilius B, Schwab A 2007. A novel function of capsaicin-sensitive TRPV1 channels. Cell Calcium 42: 17-25.
57. Zarate CA, Manji HK 2008. The role of AMPA receptor modulation in the treatment of neuropsychiatric diseases. Clin Exp Neuro 211: 7-10.
58. Zimmermann M 1983. Ethical guidelines for investigations of experimental pain in conscious animals. Pain 16: 109-110.